Blue Horseshoe Stocks: AAPL, SPY Winners & More

Apple, Inc. AAPL – Recap

We submitted two separate options trading ideas in yesterday morning’s premarket report, the first of which being the AAPL Weekly $160-162.50 Calls. It’s beeen quite some time since we played with the AAPL chain, but it is the stock that originally brought us into the fold of options day and swing trading that we’ve adopted as one of our main functions.

It came as no surprise when the Fed announced no interest rate hike yesterday that the markets responded bullishly and allowed for some very nice multi-bag moves on our designated targets.

$160 Calls – Range: 2.14-6.32 – Max Gain: 195%
$162.50 Calls – Range: 1.05-4.19 – Max Gain: 299%
_____

SPDR S&P 500 ETF (SPY) – Recap 

Our second set of options ideas from yesterday were the SPY Weekly $264-265.50 Calls, and of course, those also fared well with the SPY being an excellent market analog, and another well that we revisit on a regular basis for short term options plays.

The gains on our highlighted contracts were even more impressive in this case, with each and every strike point returning potential gains ranging from 343-598% in a single session.

$264 Calls – Range: 1.07-4.74 – Max Gain: 343%
$264.50 Calls – Range: .82-4.03 – Max Gain: 385%
$265 Calls – Range: .59-3.50 – Max Gain: 493%
$265.50 Calls – Range: .43-3.00 – Max Gain: 598%

_____

Fresh Options Ideas:
UPS Weekly $104-107 Calls
MA Weekly $207.50-217.50 Calls


Extended Watchlist:
YRCW, PTIE, TEX, FRED, GERN, GOL, GE. APRN, BIOC, EGO

Blue Horseshoe Stocks: CELZ Recap & More

Creative Medical Technology Holdings, Inc. CELZ

We mentioned CELZ at the outset of this week, in our report from Monday morning, and we wanted to return today to recap the stock’s excellent performance since then. On Monday a low of .0283 was recorded, and after a few bullish sessions it attained a new high of .0575 yesterday.

That worked out to a three-day increase of 103% on steadily rising volume, and with the PPS now currently in blue skies, we’re going to be very interested to continue monitoring the activity in CELZ as we head into week’s end.


General Mills, Inc. GIS

We would also like to recap the performance of the options ideas we submitted for General Mills yesterday. The pair of contracts we highlighted, the GIS Weekly $45 & $47.50 Calls, each managed to produce notable intraday moves.

The $45 Calls ran from a low of 1.22 to as much as 2.39 for a gain of 96% The $47.50’s fared slightly better, trading up from a low of .34 to .78; a 129% single-session rip.
_______

Fresh Options Idea:
Accenture plc. ACN Weekly $157.50-162.50 Calls


Extended Watchlist:
GST, RGSE, CLDC. MYSZ, RPM, WATT, PTIE(Bottom watch)

Blue Horseshoe Stocks: MRTX Recap & More

 Mirati Therapeutics, Inc. MRTX

After reporting positive cancer trial results on Friday, we talked about MRTX being poised for a big move and we weren’t incorrect.

The stock exploded out of the gate right from the outset, and traded in an impressive range from 9.15 to 12.40 early on in the day. That was good for a 35% intraday run- excellent for a $9+ stock. This is the third time in as many weeks we’ve called a stock that was approaching the ten dollar range and saw it gain more than a third in value in a single session.

Not only did MRTX trade up big on many times more thanits average volume, but it managed to maintain well over half of its daily advance, so we’ll be interested to continue monitoring its activity as we kick off a fresh trading week.


Iconic Brands, Inc. ICNB

We want to place ICNB on bottom-watch after taking a look at the recent history of the chart. This stock exhibits some really nice volatility and is coming down off of a significant spike.

When it finds support and rebounds, we could see a notable swing trade opportunity. The last such swing took the stock from the .003 range to .014.

The company recently announced its brand of Prosecco endorsed by former supermodel Christie Brinkley would be carried by Publix stores, so we’ll also be looking for further updates on that part of the story as well.


Pluristem Therapeutics, Inc. PSTI

We tagged PSTI for observation roughly a month ago, and have since seen a moderate move up on the chart, and will want to continue monitoring the situation.

The run the stock has made thus far is a marginal 27%, but things this morning have taken an interesting turn as the company announced the FDA granted fast track status to one of its treatments.


Extended Watchlist:
RAD, ADYN, NBRV, ARWR, PTIE, BIOA, MBOT, TRXC, COGT